Cannabinoid Breakdown- Analyzing the DEA’s Position on Novel Cannabinoids

Despite its brevity, the DEA letter I received last week about THCO was followed by confusion and lots of speculation in the cannabis industry about the legal status of novel and mood-altering cannabinoids. This is unfortunate, because I think the letter provided additional clarity, not just about THCO, but about cannabinoids in general. In this article, I […]

Go to Source

Powered by WPeMatico